0.4701
price down icon4.12%   -0.0202
after-market 시간 외 거래: .48 0.0099 +2.11%
loading

Turnstone Biologics Corp 주식(TSBX)의 최신 뉴스

pulisher
Nov 12, 2024

Turnstone Biologics Faces Financial and Operational Challenges - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Turnstone Biologics Reports 25% Response Rate in Cancer Trial, Extends Cash Runway to 2026 | TSBX Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 06, 2024

Turnstone advances TIL therapy for solid tumors at SITC meeting By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

Turnstone advances TIL therapy for solid tumors at SITC meeting - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Turnstone Biologics Reveals Breakthrough TIL Cancer Treatment Data at SITC 2024 | TSBX Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 02, 2024

Warning: TSBX is at high risk of performing badly - MSN

Nov 02, 2024
pulisher
Oct 16, 2024

Turnstone Biologics (NASDAQ:TSBX) & Recursion Pharmaceuticals (NASDAQ:RXRX) Critical Contrast - Defense World

Oct 16, 2024
pulisher
Oct 14, 2024

BofA downgrades Turnstone stock, citing wait-and-see approach until 2025 data - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

Turnstone fires most staff in bid to to extend runway - The Pharma Letter

Oct 14, 2024
pulisher
Oct 12, 2024

Turnstone Biologics Streamlines Operations and Leadership - Yahoo Finance

Oct 12, 2024
pulisher
Oct 12, 2024

Turnstone Biologics announces strategic cuts and focus shift - Investing.com

Oct 12, 2024
pulisher
Oct 11, 2024

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway - ForexTV.com

Oct 11, 2024
pulisher
Oct 10, 2024

Turnstone Biologics stock plunges to 52-week low of $0.45 - Investing.com

Oct 10, 2024
pulisher
Sep 28, 2024

Turnstone Biologics Corp. (NASDAQ:TSBX) Short Interest Update - Defense World

Sep 28, 2024
pulisher
Sep 25, 2024

Turnstone Biologics stock hits 52-week low at $0.58 amid sharp decline - Investing.com

Sep 25, 2024
pulisher
Sep 20, 2024

Analyzing Organovo (NASDAQ:ONVO) & Turnstone Biologics (NASDAQ:TSBX) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Reviewing Krystal Biotech (NASDAQ:KRYS) & Turnstone Biologics (NASDAQ:TSBX) - Defense World

Sep 19, 2024
pulisher
Sep 04, 2024

Turnstone Biologics stock plunges to 52-week low of $0.67 - Investing.com

Sep 04, 2024
pulisher
Sep 04, 2024

Turnstone Biologics stock plunges to 52-week low of $0.67 By Investing.com - Investing.com Canada

Sep 04, 2024
pulisher
Sep 02, 2024

Taking on analysts’ expectations and winning: Turnstone Biologics Corp (TSBX) - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

Investor’s Delight: Turnstone Biologics Corp (TSBX) Closes Strong at 0.70, Up 1.15 - The Dwinnex

Sep 02, 2024
pulisher
Sep 02, 2024

Is Turnstone Biologics Corp (TSBX) a good investment opportunity? - US Post News

Sep 02, 2024
pulisher
Aug 29, 2024

Turnstone Biologics Corp. (NASDAQ:TSBX) Sees Significant Increase in Short Interest - Defense World

Aug 29, 2024
pulisher
Aug 27, 2024

Turnstone Biologics stock plunges to 52-week low of $0.72 - Investing.com

Aug 27, 2024
pulisher
Aug 23, 2024

Turnstone Biologics price target lowered to $10 from $12 at BofA - TipRanks

Aug 23, 2024
pulisher
Aug 22, 2024

Tourmaline Bio (NASDAQ:TRML) versus Turnstone Biologics (NASDAQ:TSBX) Head-To-Head Review - Defense World

Aug 22, 2024
pulisher
Aug 21, 2024

The time has not yet come to remove your chips from the table: Turnstone Biologics Corp (TSBX) - SETE News

Aug 21, 2024
pulisher
Aug 20, 2024

Turnstone Biologics Corp’s results are impressive - US Post News

Aug 20, 2024
pulisher
Aug 20, 2024

Turnstone Biologics (NASDAQ:TSBX) Price Target Cut to $3.75 by Analysts at Piper Sandler - Defense World

Aug 20, 2024
pulisher
Aug 19, 2024

Turnstone Biologics shares target cut by Piper Sandler with no rating change - Investing.com

Aug 19, 2024
pulisher
Aug 19, 2024

TSBX’s Stock Market Adventure: -70.07% YTD Growth Amidst Volatility - The InvestChronicle

Aug 19, 2024
pulisher
Aug 19, 2024

Market Momentum: Turnstone Biologics Corp (TSBX) Registers a -8.24 Decrease, Closing at 0.76 - The Dwinnex

Aug 19, 2024
pulisher
Aug 19, 2024

Turnstone Biologics price target lowered to $3.75 from $20 at Piper Sandler - TipRanks

Aug 19, 2024
pulisher
Aug 16, 2024

SVB Securities slashes price target on Turnstone Biologics Corp [TSBX] – find out why. - The DBT News

Aug 16, 2024
pulisher
Aug 16, 2024

Turnstone Biologics (NASDAQ:TSBX) Releases Quarterly Earnings Results, Misses Estimates By $0.08 EPS - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Take off with Turnstone Biologics Corp (TSBX): Get ready for trading - SETE News

Aug 16, 2024
pulisher
Aug 15, 2024

Turnstone Biologics stock plunges to 52-week low of $1.36 By Investing.com - Investing.com Canada

Aug 15, 2024
pulisher
Aug 15, 2024

Why Is Turnstone Biologics Stock Trading Lower On Thursday?Turnstone Biologics (NASDAQ:TSBX) - Benzinga

Aug 15, 2024
pulisher
Aug 15, 2024

Turnstone Biologics stock plunges to 52-week low of $1.36 - Investing.com

Aug 15, 2024
pulisher
Aug 15, 2024

Turnstone reports positive early trial results for cancer therapy - Investing.com

Aug 15, 2024
pulisher
Aug 15, 2024

Why Is Turnstone Biologics (TSBX) Stock Down 38% Today? - InvestorPlace

Aug 15, 2024
pulisher
Aug 14, 2024

Turnstone Biologics Reports Encouraging Phase 1 Results - TipRanks

Aug 14, 2024
pulisher
Aug 14, 2024

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights - ForexTV.com

Aug 14, 2024
pulisher
Aug 14, 2024

Turnstone Biologics reports Q2 EPS (92c), consensus (93c) - TipRanks

Aug 14, 2024
pulisher
Aug 14, 2024

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer - StockTitan

Aug 14, 2024
pulisher
Aug 12, 2024

Turnstone Biologics Corp. (TSBX): This Penny Stock is a ‘Strong Buy’ According to Analysts - Insider Monkey

Aug 12, 2024
pulisher
Jul 13, 2024

Turnstone Biologics Corp. (NASDAQ:TSBX) Short Interest Down 20.5% in June - MarketBeat

Jul 13, 2024
pulisher
Jul 04, 2024

Can you still get a good price for Turnstone Biologics Corp (TSBX) Shares at this point? – US Post News - US Post News

Jul 04, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
자본화:     |  볼륨(24시간):